Thyroid Cancer Trial, Recruiting NCT07033572 Sponsor: Fujian Medical University Condition: Thyroid Cancer
Back to Thyroid Cancer

Thyroid Cancer Trial, Recruiting

NCT07033572
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults between 18 and 65 years old
  • People who have a small thyroid cancer (no larger than 1.5 cm) on the dominant side of the thyroid that is suitable for removal using an endoscopic (camera-guided) procedure
  • People who have a small nodule (no larger than 7 mm) on the opposite side of the thyroid, located at least 2 mm away from the back of the thyroid gland
  • People who have no signs of cancer spread to lymph nodes on the opposite side of the thyroid, based on imaging results
  • People who are willing and able to provide written consent to participate

Who may not be able to join:

  • People whose cancer has grown outside the thyroid gland, or who have known spread to nearby lymph nodes or other parts of the body
  • People who have previously had neck surgery, a procedure called radiofrequency ablation (RFA) or ethanol injection to the thyroid, or radiation treatment to the neck area
  • People who are pregnant or breastfeeding
  • People who have serious health conditions that would make it unsafe to undergo anaesthesia or to attend follow-up appointments

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Bo Wang MD, Principal Investigator, Fujian Medical University Union Hospital

Phone: +13959123550

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Fujian Medical University
Registry
ClinicalTrials.gov
Start date
1 June 2018
Est. completion
30 June 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Structural Recurrence-Free Survival; Endocrine-Function Preservation

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov